Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1333–1334
Journal	Nuclear Medicine Communications
Volume	37
Issue number	12
DOIs	https://doi.org/10.1097/MNM.0000000000000584
Publication status	Published - Dec 2016

Access to Document

@article{c0f52f900085420aac7f9913a09c95a1,

title = "Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?",

author = "Adams, \{Hugo J A\} and Kwee, \{Thomas C.\}",

year = "2016",

month = dec,

doi = "10.1097/MNM.0000000000000584",

language = "English",

volume = "37",

pages = "1333–1334",

journal = "Nuclear Medicine Communications",

issn = "0143-3636",